{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T09:12:33Z","timestamp":1788599553590,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFA0919900"],"award-info":[{"award-number":["2024YFA0919900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bmc.2026.118777","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T16:16:38Z","timestamp":1786637798000},"page":"118777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis and biological evaluation of triazolo[1,5-a]pyrimidinone derivatives as potent and orally efficacious WRN helicase inhibitors for MSI cancer therapy"],"prefix":"10.1016","volume":"142","author":[{"given":"Yi","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanbing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjiang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118777_bb0005","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41392-021-00648-7","article-title":"DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.bmc.2026.118777_bb0010","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41571-025-01054-6","article-title":"Therapeutic targeting of mismatch repair-deficient cancers","volume":"22","author":"Johannet","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.bmc.2026.118777_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00073","article-title":"Landscape of microsatellite instability across 39 cancer types","volume":"1","author":"Bonneville","year":"2017","journal-title":"JCO Precis Oncol"},{"issue":"23","key":"10.1016\/j.bmc.2026.118777_bb0020","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability-high advanced colorectal cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2026.118777_bb0025","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1807929","article-title":"Epidemiology of microsatellite instability high (MSI-H) and deficient mismatch repair (dMMR) in solid tumors: a structured literature review","volume":"2020","author":"Lorenzi","year":"2020","journal-title":"J Oncol"},{"issue":"7753","key":"10.1016\/j.bmc.2026.118777_bb0030","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41586-019-1102-x","article-title":"WRN helicase is a synthetic lethal target in microsatellite unstable cancers","volume":"568","author":"Chan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2026.118777_bb0035","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.43333","article-title":"Werner syndrome helicase is a selective vulnerability of microsatellite instability-high tumor cells","volume":"8","author":"Lieb","year":"2019","journal-title":"Elife"},{"issue":"7828","key":"10.1016\/j.bmc.2026.118777_bb0040","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41586-020-2769-8","article-title":"Repeat expansions confer WRN dependence in microsatellite-unstable cancers","volume":"586","author":"van Wietmarschen","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bmc.2026.118777_bb0045","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1158\/2159-8290.CD-24-0052","article-title":"Novel WRN helicase inhibitors selectively target microsatellite-unstable cancer cells","volume":"14","author":"Picco","year":"2024","journal-title":"Cancer Discov"},{"key":"10.1016\/j.bmc.2026.118777_bb0050","doi-asserted-by":"crossref","first-page":"12334","DOI":"10.1093\/nar\/gkae807","article-title":"Switch-like phosphorylation of WRN integrates end-resection with RAD51 metabolism at collapsed replication forks","volume":"52","author":"Palermo","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"10.1016\/j.bmc.2026.118777_bb0055","doi-asserted-by":"crossref","first-page":"7590","DOI":"10.1074\/jbc.M709707200","article-title":"Regulation of WRN protein cellular localization and enzymatic activities by SIRT1-mediated deacetylation","volume":"283","author":"Li","year":"2008","journal-title":"J Biol Chem"},{"issue":"14","key":"10.1016\/j.bmc.2026.118777_bb0060","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1038\/s41388-018-0605-5","article-title":"MDM2-mediated degradation of WRN promotes cellular senescence in a p53-independent manner","volume":"38","author":"Liu","year":"2019","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.bmc.2026.118777_bb0065","doi-asserted-by":"crossref","first-page":"11488","DOI":"10.1096\/fj.202000268RRR","article-title":"MIB1-mediated degradation of WRN promotes cellular senescence in response to camptothecin treatment","volume":"34","author":"Li","year":"2020","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.bmc.2026.118777_bb0070","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.1038\/s41467-024-50178-3","article-title":"WRN inhibition leads to its chromatin-associated degradation via the PIAS4-RNF4-p97\/VCP axis","volume":"15","author":"Rodr\u00edguez P\u00e9rez","year":"2024","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.bmc.2026.118777_bb0075","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1093\/nar\/gkx065","article-title":"WRN is recruited to damaged telomeres via its RQC domain and tankyrase1-mediated poly-ADP-ribosylation of TRF1","volume":"45","author":"Sun","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.bmc.2026.118777_bb0080","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.1038\/s41467-024-50987-6","article-title":"SNORD88B-mediated WRN nucleolar trafficking drives self-renewal in liver cancer initiating cells and hepatocarcinogenesis","volume":"15","author":"Gu","year":"2024","journal-title":"Nat Commun"},{"issue":"8011","key":"10.1016\/j.bmc.2026.118777_bb0085","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41586-024-07350-y","article-title":"Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancers","volume":"629","author":"Ferretti","year":"2024","journal-title":"Nature"},{"issue":"8011","key":"10.1016\/j.bmc.2026.118777_bb0090","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41586-024-07318-y","article-title":"Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase","volume":"629","author":"Baltgalvis","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2026.118777_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2026.118842","article-title":"Targeting WRN helicase in MSI-H tumors: synthetic lethality, small molecule discovery, and therapeutic perspectives","volume":"311","author":"Pu","year":"2026","journal-title":"Eur J Med Chem"},{"issue":"12","key":"10.1016\/j.bmc.2026.118777_bb0100","doi-asserted-by":"crossref","first-page":"12434","DOI":"10.1021\/acs.jmedchem.4c03029","article-title":"Validation, key pharmacophores, and x-ray cocrystal structures of novel biochemically and cellularly active WRN inhibitors derived from a DNA-encoded library screen","volume":"68","author":"Tong","year":"2025","journal-title":"J Med Chem"},{"issue":"12","key":"10.1016\/j.bmc.2026.118777_bb0105","doi-asserted-by":"crossref","first-page":"14492","DOI":"10.1021\/acs.jmedchem.6c00331","article-title":"Structure-guided discovery of potent, selective, and orally bioavailable Werner syndrome RecQ helicase inhibitors for the treatment of microsatellite instability-high tumors","volume":"69","author":"Sui","year":"2026","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118777_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2025.130141","article-title":"Discovery of novel WRN inhibitors for treating MSI-H colorectal cancers","volume":"120","author":"Moon","year":"2025","journal-title":"Bioorg Med Chem Lett"},{"issue":"8 Suppl 1","key":"10.1016\/j.bmc.2026.118777_bb0115","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1158\/1538-7445.AM2025-5750","article-title":"Discovery of GSK4418959 (IDE275): a novel, non-covalent, reversible Werner helicase inhibitor for the treatment of MSI-H cancers","volume":"85","author":"Taygerly","year":"2025","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmc.2026.118777_bb0120","doi-asserted-by":"crossref","unstructured":"Lemech C, Humphries T, Biachi de Castria T, et al. Orally administered MOMA-341 as monotherapy or combination therapy in participants with advanced or metastatic solid tumors: phase 1 study design. Mol Cancer Ther 2025; 24(10 Suppl), B003.","DOI":"10.1158\/1535-7163.TARG-25-B003"},{"issue":"8 Suppl 1","key":"10.1016\/j.bmc.2026.118777_bb0125","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1158\/1538-7445.AM2025-2894","article-title":"NTX-452: a non-covalent, potent, selective and highly efficacious WRN inhibitor with best-in-class potential for the treatment of MSI-H tumors","volume":"85","author":"Svensson","year":"2025","journal-title":"Cancer Res"},{"issue":"6 Suppl","key":"10.1016\/j.bmc.2026.118777_bb0130","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.1158\/1538-7445.AM2024-5921","article-title":"PH027-1, a potent and selective small-molecule WRN inhibitor that targets MSI-H tumors","volume":"4","author":"Gao","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmc.2026.118777_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-71160-5","article-title":"PROTAC-mediated conditional degradation of the WRN helicase as a potential strategy for selective killing of cancer cells with microsatellite instability","volume":"14","author":"Tejwani","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2026.118777_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118121","article-title":"Targeted degradation of Werner syndrome helicase (WRN) via ligand-directed covalent hydrophobic tagging","volume":"300","author":"Tao","year":"2025","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118777_bb0145","series-title":"Triazolo-pyrimidine analogues for treating diseases connected to the inhibition of Werner Syndrome RECQ helicase (WRN)","author":"Bordas","year":"2022"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T08:36:30Z","timestamp":1788597390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626002336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":29,"alternative-id":["S0968089626002336"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118777","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of triazolo[1,5-a]pyrimidinone derivatives as potent and orally efficacious WRN helicase inhibitors for MSI cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118777","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118777"}}